Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ATM deletion + SF3B1 mutation
i
Other names:
ATM, ATA, ATC, ATD, ATDC, TEL1, TELO1, ATM serine/threonine kinase, SF3B1, Splicing Factor 3b Subunit 1, Splicing Factor 3b Subunit 1 155kDa, Spliceosome-Associated Protein 155, Splicing Factor 3B Subunit 1, SF3b155, SAP155, Pre-MRNA Splicing Factor SF3b 155 KDa Subunit, Pre-MRNA-Splicing Factor SF3b 155 KDa Subunit, Splicing Factor 3b Subunit 1 155kD, Pre-MRNA Processing 10, SAP 155, Hsh155, PRPF10, PRP10, MDS
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
472
;
23451
Related biomarkers:
Expression
Mutation
CNA
Others
‹
Chr del(13q) + Chr del(11q) + SF3B1 mutation (3)
Chr del(11q) + ATM mutation (2)
ATM expression + ATM T2333fs* + EGFR negative (1)
BRCA2 deletion + ATM mutation (1)
SF3B1 mutation + Chr del(5q) (1)
Chr del(13q) + Chr del(11q) + SF3B1 mutation (3)
Chr del(11q) + ATM mutation (2)
ATM expression + ATM T2333fs* + EGFR negative (1)
BRCA2 deletion + ATM mutation (1)
SF3B1 mutation + Chr del(5q) (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ATM deletion + SF3B1 mutation
Chronic Lymphocytic Leukemia
ATM deletion + SF3B1 mutation
Chronic Lymphocytic Leukemia
S63845
Sensitive: D – Preclinical
S63845
Sensitive
:
D
S63845
Sensitive: D – Preclinical
S63845
Sensitive
:
D
ATM deletion + SF3B1 mutation
Chronic Lymphocytic Leukemia
ATM deletion + SF3B1 mutation
Chronic Lymphocytic Leukemia
idelalisib
Resistant: D – Preclinical
idelalisib
Resistant
:
D
idelalisib
Resistant: D – Preclinical
idelalisib
Resistant
:
D
ATM deletion + SF3B1 mutation
Chronic Lymphocytic Leukemia
ATM deletion + SF3B1 mutation
Chronic Lymphocytic Leukemia
duvelisib
Resistant: D – Preclinical
duvelisib
Resistant
:
D
duvelisib
Resistant: D – Preclinical
duvelisib
Resistant
:
D
ATM deletion + SF3B1 mutation
Chronic Lymphocytic Leukemia
ATM deletion + SF3B1 mutation
Chronic Lymphocytic Leukemia
umbralisib
Resistant: D – Preclinical
umbralisib
Resistant
:
D
umbralisib
Resistant: D – Preclinical
umbralisib
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.